These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 17549414)
1. Small interfering RNA against PTTG: a novel therapy for ovarian cancer. El-Naggar SM; Malik MT; Kakar SS Int J Oncol; 2007 Jul; 31(1):137-43. PubMed ID: 17549414 [TBL] [Abstract][Full Text] [Related]
2. Suppression of lung cancer with siRNA targeting PTTG. Kakar SS; Malik MT Int J Oncol; 2006 Aug; 29(2):387-95. PubMed ID: 16820881 [TBL] [Abstract][Full Text] [Related]
3. [Construction of PTTGas antisense expression vector and its inhibitory effects on human ovarian carcinoma cell line SK-OV-3]. Chen G; Li J; Li FJ; Zhou JF; Lu YP; Ma D Ai Zheng; 2003 Oct; 22(10):1009-13. PubMed ID: 14558940 [TBL] [Abstract][Full Text] [Related]
4. Stable suppression of HER-2 gene expression using siRNA increases the lysis of human ovarian carcinoma cells mediated by NK-92 cell line. Zhou Y; Cheng Z; Zhu H; Feng D; Zhao W; Ling B; Wei H; Tian Z Oncol Rep; 2008 Dec; 20(6):1425-31. PubMed ID: 19020724 [TBL] [Abstract][Full Text] [Related]
5. [Construction of a gastric cancer related gene GCRG213-specific siRNA expression vector and its effect on gastric cancer cells in vitro]. Gao LL; Wu BY; Wang MW; Zhan DW; Zhang L; You WD; Wang WH Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):84-8. PubMed ID: 17645837 [TBL] [Abstract][Full Text] [Related]
6. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference. Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596 [TBL] [Abstract][Full Text] [Related]
7. Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer. Yang G; Thompson JA; Fang B; Liu J Oncogene; 2003 Aug; 22(36):5694-701. PubMed ID: 12944918 [TBL] [Abstract][Full Text] [Related]
8. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer]. Liu JP; Yuan SZ; Zhang SN Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254 [TBL] [Abstract][Full Text] [Related]
9. Pituitary tumor-transforming gene (PTTG): a novel target for anti-tumor therapy. Solbach C; Roller M; Peters S; Nicoletti M; Kaufmann M; Knecht R Anticancer Res; 2005; 25(1A):121-5. PubMed ID: 15816528 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209 [TBL] [Abstract][Full Text] [Related]
11. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2. Fang L; Hu Q; Hua Z; Li S; Dong W Int J Oral Maxillofac Surg; 2008 Sep; 37(9):847-52. PubMed ID: 18620845 [TBL] [Abstract][Full Text] [Related]
13. Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice. El-Naggar SM; Malik MT; Martin A; Moore JP; Proctor M; Hamid T; Kakar SS J Endocrinol; 2007 Jul; 194(1):179-91. PubMed ID: 17592032 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting tumor growth of colorectal cancer by blocking the expression of vascular endothelial growth factor receptor 3 using interference vector-based RNA interference. Lui Z; Ma Q; Wang X; Zhang Y Int J Mol Med; 2010 Jan; 25(1):59-64. PubMed ID: 19956902 [TBL] [Abstract][Full Text] [Related]
15. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Jonson AL; Rogers LM; Ramakrishnan S; Downs LS Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502 [TBL] [Abstract][Full Text] [Related]
16. [Effects of small interfering RNA specific for Her-2 gene on biological behavior of ovarian carcinoma cell]. Zhou Y; Ling B; Feng DQ; Cheng ZX; Shen GD; Gao T; Shi YY; Wang MM; Zhao WD; Zhu HP Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):830-3. PubMed ID: 17327114 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells. Chen T; Deng C Int Immunopharmacol; 2008 Jul; 8(7):1006-11. PubMed ID: 18486912 [TBL] [Abstract][Full Text] [Related]
18. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes. Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350 [TBL] [Abstract][Full Text] [Related]
19. [Inhibition of invasive and chemotactic abilities of SKOV3 cells by human epithelial growth receptor-2 small interfering RNA]. Zhang SL; Lu YM; Meng LR; Zhao YY Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):48-53. PubMed ID: 17331422 [TBL] [Abstract][Full Text] [Related]
20. DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells. Sanlioglu AD; Karacay B; Koksal IT; Griffith TS; Sanlioglu S Cancer Gene Ther; 2007 Dec; 14(12):976-84. PubMed ID: 17853923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]